English

UNUM THERAPEUTICS INC.

EDGAR

COGT Quarterly report (10-Q) · filed 2026-08-10

44 filing records in this dataset, filed from 2018-03-02 to 2026-08-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 181 million USD 2026-06-30 Source
Exact value

181172000 USD
Long-term debt including current maturities: 223 million USD 2026-06-30 Source
Exact value

223457000 USD
Shares outstanding: 172 million shares 2026-06-30 Source
Exact value

171598409 shares

Reported share-count change

50.62% · 57.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

113928492 shares · 2025-06-30· Source
171598409 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-377 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -80930000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -328937000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -226445000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -97352000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -96405000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-308 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -185339000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -121053000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -264444000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -185339000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -86883000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -164154000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -86883000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

1.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 743000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 678000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1554000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 743000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 449000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 819000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 449000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-309 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -185339000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -121053000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -264444000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -185339000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -86883000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -164154000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -86883000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 743000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 678000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 1554000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 743000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 449000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 819000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 449000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-10.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2025-12-31
Shares outstanding: 9 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 73.08 million

Prior period

−USD 255.86 million

2024-01-01 – 2024-12-31
Current period

−USD 328.94 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-328937000 − -255859000 = -73078000 USD

-255859000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-328937000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Year-over-year change in Net income: -73078000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -328937000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#3420494 Filing: 000119312526053334 Input fundies:NetIncome: -255859000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#3422283 Filing: 000119312526053334
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 56.65 million

Prior period

−USD 207.79 million

2024-01-01 – 2024-12-31
Current period

−USD 264.44 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-264444000 − -207791000 = -56653000 USD

-207791000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-264444000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Year-over-year change in Operating cash flow: -56653000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -264444000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2044773 Filing: 000119312526053334 Input fundies:OperatingCashFlow: -207791000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2046654 Filing: 000119312526053334
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+171.2%

Prior period

USD 573,000

2024-01-01 – 2024-12-31
Current period

USD 1.55 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

1554000 − 573000 = 981000 USD

573000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1554000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Year-over-year change in Capital expenditure: 981000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1554000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2054345 Filing: 000119312526053334 Input fundies:CapitalExpenditure: 573000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2056111 Filing: 000119312526053334
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−USD 25.49 million Exact value Exact value: -25492000 USD 2017-01-01 – 2017-12-31: -25492000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2017-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -25492000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25492000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/umrx-20181231.xml#91761 Filing: 000119312519089299 The citation records this snapshot. The page link may show a newer release later.	−USD 25.84 million Exact value Exact value: -25835000 USD 2017-01-01 – 2017-12-31: -25835000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2017-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -25835000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25835000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/umrx-20181231.xml#91492 Filing: 000119312519089299 The citation records this snapshot. The page link may show a newer release later.	USD 912,000 Exact value Exact value: 912000 USD 2017-01-01 – 2017-12-31: 912000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2017-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 912000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 912000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/umrx-20181231.xml#93602 Filing: 000119312519089299 The citation records this snapshot. The page link may show a newer release later.	−USD 26.75 million Calculation and evidence -25835000 − 912000 USD Exact free cash flow: -26747000 USD 2017-01-01 – 2017-12-31: -25835000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 912000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2017-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -26747000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25835000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/umrx-20181231.xml#91492 Filing: 000119312519089299 Input fundies:CapitalExpenditure: 912000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312519089299/umrx-20181231.xml#93602 Filing: 000119312519089299 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 34.53 million Exact value Exact value: -34532000 USD 2018-01-01 – 2018-12-31: -34532000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2018-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -34532000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34532000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/umrx-20191231.xml#105430 Filing: 000156459020013188 The citation records this snapshot. The page link may show a newer release later.	−USD 32.49 million Exact value Exact value: -32489000 USD 2018-01-01 – 2018-12-31: -32489000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2018-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -32489000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32489000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/umrx-20191231.xml#127293 Filing: 000156459020013188 The citation records this snapshot. The page link may show a newer release later.	USD 549,000 Exact value Exact value: 549000 USD 2018-01-01 – 2018-12-31: 549000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2018-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 549000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 549000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/umrx-20191231.xml#127713 Filing: 000156459020013188 The citation records this snapshot. The page link may show a newer release later.	−USD 33.04 million Calculation and evidence -32489000 − 549000 USD Exact free cash flow: -33038000 USD 2018-01-01 – 2018-12-31: -32489000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 549000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2018-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -33038000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32489000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/umrx-20191231.xml#127293 Filing: 000156459020013188 Input fundies:CapitalExpenditure: 549000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459020013188/umrx-20191231.xml#127713 Filing: 000156459020013188 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 31.83 million Exact value Exact value: -31833000 USD 2019-01-01 – 2019-12-31: -31833000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2019-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -31833000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31833000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459021013325/cogt-20201231.xml#139664 Filing: 000156459021013325 The citation records this snapshot. The page link may show a newer release later.	−USD 41.51 million Exact value Exact value: -41514000 USD 2019-01-01 – 2019-12-31: -41514000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2019-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -41514000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41514000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459021013325/cogt-20201231.xml#167466 Filing: 000156459021013325 The citation records this snapshot. The page link may show a newer release later.	USD 33,000 Exact value Exact value: 33000 USD 2019-01-01 – 2019-12-31: 33000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2019-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 33000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459021013325/cogt-20201231.xml#167678 Filing: 000156459021013325 The citation records this snapshot. The page link may show a newer release later.	−USD 41.55 million Calculation and evidence -41514000 − 33000 USD Exact free cash flow: -41547000 USD 2019-01-01 – 2019-12-31: -41514000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 33000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2019-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -41547000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41514000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459021013325/cogt-20201231.xml#167466 Filing: 000156459021013325 Input fundies:CapitalExpenditure: 33000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459021013325/cogt-20201231.xml#167678 Filing: 000156459021013325 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 74.81 million Exact value Exact value: -74808000 USD 2020-01-01 – 2020-12-31: -74808000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2020-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -74808000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74808000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459022010238/cogt-10k_20211231.htm#2328976 Filing: 000156459022010238 The citation records this snapshot. The page link may show a newer release later.	−USD 35.85 million Exact value Exact value: -35850000 USD 2020-01-01 – 2020-12-31: -35850000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2020-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -35850000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35850000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000156459022010238/cogt-10k_20211231.htm#1515037 Filing: 000156459022010238 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 72.27 million Exact value Exact value: -72273000 USD 2021-01-01 – 2021-12-31: -72273000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2021-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -72273000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -72273000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm#2262854 Filing: 000095017024019770 The citation records this snapshot. The page link may show a newer release later.	−USD 58.76 million Exact value Exact value: -58763000 USD 2021-01-01 – 2021-12-31: -58763000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2021-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -58763000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58763000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm#1428885 Filing: 000095017024019770 The citation records this snapshot. The page link may show a newer release later.	USD 1.72 million Exact value Exact value: 1719000 USD 2021-01-01 – 2021-12-31: 1719000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2021-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 1719000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm#1435697 Filing: 000095017024019770 The citation records this snapshot. The page link may show a newer release later.	−USD 60.48 million Calculation and evidence -58763000 − 1719000 USD Exact free cash flow: -60482000 USD 2021-01-01 – 2021-12-31: -58763000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1719000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2021-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -60482000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58763000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm#1428885 Filing: 000095017024019770 Input fundies:CapitalExpenditure: 1719000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm#1435697 Filing: 000095017024019770 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 140.24 million Exact value Exact value: -140241000 USD 2022-01-01 – 2022-12-31: -140241000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2022-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -140241000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -140241000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm#3200973 Filing: 000095017025026115 The citation records this snapshot. The page link may show a newer release later.	−USD 118.64 million Exact value Exact value: -118638000 USD 2022-01-01 – 2022-12-31: -118638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2022-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -118638000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -118638000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm#1934695 Filing: 000095017025026115 The citation records this snapshot. The page link may show a newer release later.	USD 6.86 million Exact value Exact value: 6863000 USD 2022-01-01 – 2022-12-31: 6863000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2022-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 6863000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6863000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm#1943835 Filing: 000095017025026115 The citation records this snapshot. The page link may show a newer release later.	−USD 125.5 million Calculation and evidence -118638000 − 6863000 USD Exact free cash flow: -125501000 USD 2022-01-01 – 2022-12-31: -118638000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 6863000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2022-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -125501000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -118638000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm#1934695 Filing: 000095017025026115 Input fundies:CapitalExpenditure: 6863000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm#1943835 Filing: 000095017025026115 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 192.41 million Exact value Exact value: -192410000 USD 2023-01-01 – 2023-12-31: -192410000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2023-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -192410000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -192410000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#3424072 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 153.62 million Exact value Exact value: -153624000 USD 2023-01-01 – 2023-12-31: -153624000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2023-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -153624000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -153624000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2048535 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	USD 2.8 million Exact value Exact value: 2796000 USD 2023-01-01 – 2023-12-31: 2796000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2023-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 2796000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2796000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2057875 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 156.42 million Calculation and evidence -153624000 − 2796000 USD Exact free cash flow: -156420000 USD 2023-01-01 – 2023-12-31: -153624000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 2796000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2023-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -156420000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -153624000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2048535 Filing: 000119312526053334 Input fundies:CapitalExpenditure: 2796000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2057875 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 255.86 million Exact value Exact value: -255859000 USD 2024-01-01 – 2024-12-31: -255859000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2024-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -255859000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -255859000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#3422283 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 207.79 million Exact value Exact value: -207791000 USD 2024-01-01 – 2024-12-31: -207791000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2024-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -207791000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -207791000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2046654 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	USD 573,000 Exact value Exact value: 573000 USD 2024-01-01 – 2024-12-31: 573000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2024-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 573000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 573000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2056111 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 208.36 million Calculation and evidence -207791000 − 573000 USD Exact free cash flow: -208364000 USD 2024-01-01 – 2024-12-31: -207791000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 573000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2024-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -208364000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -207791000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2046654 Filing: 000119312526053334 Input fundies:CapitalExpenditure: 573000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2056111 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 328.94 million Exact value Exact value: -328937000 USD 2025-01-01 – 2025-12-31: -328937000 USD Inspect Net Income Open source Share or cite Citation for Net Income · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Net Income: -328937000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -328937000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#3420494 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 264.44 million Exact value Exact value: -264444000 USD 2025-01-01 – 2025-12-31: -264444000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Operating Cash Flow: -264444000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -264444000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2044773 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Exact value Exact value: 1554000 USD 2025-01-01 – 2025-12-31: 1554000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Capital Expenditure: 1554000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1554000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2054345 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.	−USD 266 million Calculation and evidence -264444000 − 1554000 USD Exact free cash flow: -265998000 USD 2025-01-01 – 2025-12-31: -264444000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 1554000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · UNUM THERAPEUTICS INC. · 2025-12-31 UNUM THERAPEUTICS INC. (edgar:1622229) Free cash flow: -265998000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T10:59:44Z Snapshot: 3aef53d6b94a8e31b72d6f699cbad6a04e7c578d3a728f4249e09f9411988294 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1622229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -264444000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2044773 Filing: 000119312526053334 Input fundies:CapitalExpenditure: 1554000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm#2054345 Filing: 000119312526053334 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 2,133 latest values · 2,133 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001622229, 1622229, COGT, UMRX, edgar:1622229

Also known as COGENT BIOSCIENCES, INC., Cogent Biosciences, Inc., UNUM THERAPEUTICS INC., Unum Therapeutics Inc., Unum Therapeutics, Inc.

UNUM THERAPEUTICS INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation